nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—AR—polycystic ovary syndrome	0.982	1	CbGaD
Stanozolol—Trilostane—HSD3B1—polycystic ovary syndrome	0.00295	0.237	CrCbGaD
Stanozolol—Trilostane—HSD3B2—polycystic ovary syndrome	0.00199	0.16	CrCbGaD
Stanozolol—Oxandrolone—AR—polycystic ovary syndrome	0.00072	0.058	CrCbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—SHBG—polycystic ovary syndrome	0.000604	0.121	CbGpPWpGaD
Stanozolol—Drostanolone—SHBG—polycystic ovary syndrome	0.000546	0.044	CrCbGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—TMF1—polycystic ovary syndrome	0.000546	0.109	CbGpPWpGaD
Stanozolol—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000481	0.0387	CrCbGaD
Stanozolol—Drostanolone—AR—polycystic ovary syndrome	0.000479	0.0386	CrCbGaD
Stanozolol—Drostanolone—CYP19A1—polycystic ovary syndrome	0.000401	0.0323	CrCbGaD
Stanozolol—AR—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.000347	0.0695	CbGpPWpGaD
Stanozolol—Danazol—PGR—polycystic ovary syndrome	0.000316	0.0254	CrCbGaD
Stanozolol—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000309	0.0249	CrCbGaD
Stanozolol—Danazol—SHBG—polycystic ovary syndrome	0.000295	0.0238	CrCbGaD
Stanozolol—Testosterone Propionate—AR—polycystic ovary syndrome	0.000292	0.0235	CrCbGaD
Stanozolol—Norethindrone—PGR—polycystic ovary syndrome	0.000281	0.0226	CrCbGaD
Stanozolol—Fluoxymesterone—AR—polycystic ovary syndrome	0.000271	0.0218	CrCbGaD
Stanozolol—Norethindrone—SHBG—polycystic ovary syndrome	0.000262	0.0212	CrCbGaD
Stanozolol—Danazol—AR—polycystic ovary syndrome	0.000259	0.0209	CrCbGaD
Stanozolol—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000249	0.0201	CrCbGaD
Stanozolol—Progesterone—CYP17A1—polycystic ovary syndrome	0.000221	0.0178	CrCbGaD
Stanozolol—Methyltestosterone—AR—polycystic ovary syndrome	0.000219	0.0176	CrCbGaD
Stanozolol—Danazol—CYP19A1—polycystic ovary syndrome	0.000217	0.0175	CrCbGaD
Stanozolol—AR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000214	0.0429	CbGpPWpGaD
Stanozolol—Testosterone—CYP11A1—polycystic ovary syndrome	0.000205	0.0165	CrCbGaD
Stanozolol—AR—Notch-mediated HES/HEY network—CAMK2D—polycystic ovary syndrome	0.000185	0.0371	CbGpPWpGaD
Stanozolol—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.000184	0.0148	CrCbGaD
Stanozolol—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000183	0.0147	CrCbGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000169	0.0339	CbGpPWpGaD
Stanozolol—Progesterone—PGR—polycystic ovary syndrome	0.000164	0.0132	CrCbGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000161	0.0322	CbGpPWpGaD
Stanozolol—Progesterone—SHBG—polycystic ovary syndrome	0.000153	0.0123	CrCbGaD
Stanozolol—Testosterone—SHBG—polycystic ovary syndrome	0.000145	0.0117	CrCbGaD
Stanozolol—AR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.000135	0.027	CbGpPWpGaD
Stanozolol—Progesterone—AR—polycystic ovary syndrome	0.000134	0.0108	CrCbGaD
Stanozolol—AR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000128	0.0256	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000128	0.0256	CbGpPWpGaD
Stanozolol—Testosterone—AR—polycystic ovary syndrome	0.000127	0.0102	CrCbGaD
Stanozolol—AR—Notch-mediated HES/HEY network—NCOR1—polycystic ovary syndrome	0.000123	0.0246	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000107	0.0213	CbGpPWpGaD
Stanozolol—Testosterone—CYP19A1—polycystic ovary syndrome	0.000106	0.00856	CrCbGaD
Stanozolol—AR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000104	0.0209	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—NR3C1—polycystic ovary syndrome	0.000103	0.0207	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—polycystic ovary syndrome	0.000102	0.0205	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	9.53e-05	0.0191	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—INS—polycystic ovary syndrome	9.1e-05	0.0182	CbGpPWpGaD
Stanozolol—Progesterone—NR3C1—polycystic ovary syndrome	9.09e-05	0.00733	CrCbGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	8.49e-05	0.017	CbGpPWpGaD
Stanozolol—Progesterone—CYP1A1—polycystic ovary syndrome	8.26e-05	0.00666	CrCbGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	8.25e-05	0.0165	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	7.95e-05	0.0159	CbGpPWpGaD
Stanozolol—Testosterone—CYP1A1—polycystic ovary syndrome	7.81e-05	0.00629	CrCbGaD
Stanozolol—AR—Androgen receptor signaling pathway—NCOR1—polycystic ovary syndrome	7.37e-05	0.0148	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	7.36e-05	0.0147	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	7.01e-05	0.014	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	6.3e-05	0.0126	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ZNF205—polycystic ovary syndrome	6.16e-05	0.0123	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ZNF430—polycystic ovary syndrome	6.16e-05	0.0123	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	6.05e-05	0.0121	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	5.89e-05	0.0118	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	5.82e-05	0.0116	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	5.68e-05	0.0114	CbGpPWpGaD
Stanozolol—AR—Gene Expression—ADARB1—polycystic ovary syndrome	5.24e-05	0.0105	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	5.13e-05	0.0103	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	4.71e-05	0.00942	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	4.35e-05	0.00872	CbGpPWpGaD
Stanozolol—AR—Gene Expression—LSM5—polycystic ovary syndrome	4.27e-05	0.00855	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SAP30L—polycystic ovary syndrome	3.97e-05	0.00794	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	3.9e-05	0.00781	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	3.55e-05	0.0071	CbGpPWpGaD
Stanozolol—AR—Gene Expression—TEAD2—polycystic ovary syndrome	3.37e-05	0.00675	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	3.35e-05	0.00671	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	2.92e-05	0.00585	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	2.87e-05	0.00574	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.72e-05	0.00545	CbGpPWpGaD
Stanozolol—AR—Gene Expression—RPL37A—polycystic ovary syndrome	2.4e-05	0.00481	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.38e-05	0.00475	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	2.14e-05	0.00429	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	2.09e-05	0.00418	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	1.99e-05	0.00398	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	1.84e-05	0.00368	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.78e-05	0.00356	CbGpPWpGaD
Stanozolol—AR—Gene Expression—YAP1—polycystic ovary syndrome	1.61e-05	0.00323	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.45e-05	0.00289	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.42e-05	0.00285	CbGpPWpGaD
Stanozolol—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	1.42e-05	0.00285	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PGR—polycystic ovary syndrome	1.41e-05	0.00282	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.28e-05	0.00257	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NCOR1—polycystic ovary syndrome	9.57e-06	0.00192	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR3C1—polycystic ovary syndrome	8.86e-06	0.00177	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARG—polycystic ovary syndrome	6.86e-06	0.00137	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	6.18e-06	0.00124	CbGpPWpGaD
